Advanced company searchLink opens in new window

KYMO THERAPEUTICS LIMITED

Company number 10194104

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
22 Jan 2019 AA Total exemption full accounts made up to 31 May 2018
22 Jun 2018 SH08 Change of share class name or designation
21 Jun 2018 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
19 Jun 2018 TM01 Termination of appointment of Alexandre Moreau as a director on 31 May 2018
04 Jun 2018 CS01 Confirmation statement made on 22 May 2018 with updates
17 Apr 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
21 Feb 2018 AA Total exemption full accounts made up to 31 May 2017
31 Jul 2017 SH01 Statement of capital following an allotment of shares on 29 June 2017
  • EUR 15,916.66
31 Jul 2017 SH10 Particulars of variation of rights attached to shares
05 Jun 2017 SH01 Statement of capital following an allotment of shares on 19 September 2016
  • EUR 15,083.33
02 Jun 2017 CS01 22/05/17 Statement of Capital eur 15083.33
03 Mar 2017 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
01 Mar 2017 AP01 Appointment of Dr Giovanni Mariggi as a director on 21 February 2017
16 Feb 2017 AP01 Appointment of Alexandre Moreau as a director on 1 February 2017
28 Oct 2016 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES12 ‐ Resolution of varying share rights or name
28 Oct 2016 AP01 Appointment of Valerie Autier as a director on 23 August 2016
28 Oct 2016 SH08 Change of share class name or designation
23 May 2016 NEWINC Incorporation
Statement of capital on 2016-05-23
  • EUR .01
  • MODEL ARTICLES ‐ Model articles adopted